Abstract Palladium-catalyzed germylation of aryl bromides and aryl triflates using commercially available hexamethyldigermane is described. Optimized reaction conditions afforded various functionalized aryltrimethylgermanes, including drug-like molecules, in moderate to good yield, demonstrating the versatility of the presented protocols.
arylsilanes without using aryllithium or Grignard reagents. On the other hand, studies of transition metal-catalyzed germylation of aryl halides are scarce, 8c,9b,10h,k,11 although such reactions enable the direct synthesis of functionalized arylgermanes. Oshima achieved Pd-catalyzed germylation of aryl iodides using tri(2-furyl)germane, (Figure 1a ), 8c but electron-deficient aryl iodides were not investigated, and an aryl bromide was unreactive. Yamanoi and Nishihara reported general conditions for Pd-catalyzed coupling reactions of various aryl iodides and hydrogermanes (Figure 1a) . 10k In contrast to aryl iodides, less reactive aryl bromides are still difficult substrates for germylation ( Figure 1b) . Earborn reported Pd-catalyzed germylation of aryl bromides with hexaethyldigermane, but the reactions required harsh conditions (140-180 °C) and resulted in a low yield. 9b Tanaka reported Pd-catalyzed germylation of bromobenzene and 2,5-dibromothiophene, but moisture sensitive dichlorotetramethyldigermane was required, and the results were rather complicated due to halogen exchange. 11 To date, general and practical conditions for transition metal-catalyzed germylation of aryl bromides and aryl triflates have not been reported.
In this article, we report Pd-catalyzed germylation of aryl bromides 1 and aryl triflates 2 using commercially available hexamethyldigermane 3 (Figure 1c ). We initiated our investigation by optimizing the reaction conditions for germylation of aryl bromide 1a using hexamethyldigermane 3 (Table 1 , entries 1-10). We selected the reaction conditions of Pd-catalyzed silylation of aryl halides with hexamethyldisilane reported by Shirakawa and Hiyama 9g as the initial conditions (entries 1,2). These conditions afforded the desired germylated arene 4a in moderate yield along with several byproducts. GC/MS analysis revealed the formation of reduced product 6, biaryl 7, and unidentified products bearing an allyl or propenyl group. We next investigated other palladium sources using toluene/H2O as the solvent to circumvent incorporation of the C3 units derived from [PdCl(allyl)]2. While Pd2(dba)3 exhibited inferior catalytic activity (entry 3), the use of Pd(OAc)2 resulted in 62% yield (entry 4). In these cases, incorporation of the C3 unit was avoided, but a significant amount of 7 was produced. Several bases and phase transfer catalysts (PTC) were then screened to improve the selectivity (entries 5-9), and Cs2CO3 and Et4NHCO3 were the most effective for providing 4a in 93% yield, with only a tiny amount of 6 (entry 9). We performed a control experiment using PPh3 as a ligand instead of 5 (entry 10). The reaction unexpectedly proceeded with moderate yield, but a relatively large amount of phenyl(trimethyl)germane 8 was observed. This byproduct would be formed by reduction of 4a or an aryl-aryl exchange between an arylpalladium intermediate and PPh3 during the catalytic process. 12 We next investigated germylation of aryl triflate 2a (entries 11-21) . The optimized conditions for aryl bromide 1a in entry 9 afforded no products, and 2a remained intact (entry 11). The use of toluene as the sole solvent provided the desired product 3, but the yield was low and a significant amount of 9 was observed (entry 12). We speculated the lower reactivity of 2a compared with 1a might be due to the absence of a halide ion in the reaction, and several halide sources were screened as potential additives (entries [13] [14] [15] [16] [17] [18] [19] . The addition of one equivalent of Et4NBr was found to be effective, and the yield was improved to 49% (entry 19). Raising the reaction temperature to 120 °C further improved the yield (entry 20). Finally, the conditions without Et4NHCO3 resulted in a slightly better yield (entry 21), and were determined to be the optimal conditions for 2a.
Although a significant amount of 8 was observed at 120 °C, the yield of 4a based on an internal standard was high (entries 20 and 21), indicating that 8 was derived from ligand 5 rather than 2a or 4a in these cases.
The scope and limitations of the optimized conditions for germylation are summarized in Figure 2 . Both electron-deficient and electron-rich aryl bromides afforded the desired products in good yield (4a, 4b) . Various functional groups were well tolerated, providing germylated building blocks that are useful for further transformation (4c-4f). Heteroaryl bromides were reactive to give the corresponding germylated products (4g, 4h, 4i). The conditions optimized for aryl triflates (Conditions B) were more effective for less reactive aryl bromides to afford 4f, 4h and 4i. 4-Bromophenol 1j, however, failed to give the germylated product 4j, and phenol was detected as a major product under both reaction conditions. Germylated drug-like structures (4k, 13 4l 14 ) were accessible from the corresponding aryl bromides under Conditions B. In addition to aryl bromides, various types of aryl triflates afforded the desired germylated arenes. Electron-rich arenes such as 2n and 2s exhibited low reactivity (4n, 4s), while highly electron-deficient substrates resulted in low yields due to fast hydrolysis of the sulfonate group (4o, 4p). In some cases, the use of KOAc instead of Cs2CO3 was beneficial for avoiding the hydrolysis (4o, 4u). Moderately electron-deficient aryl triflates were good substrates, and the products were obtained in good yield (4a, 4q, 4r, 4h) under the standard conditions. The triflate of estrone 2t exhibited low reactivity, but moderate yield was obtained using 20 mol % of Pd(OAc)2 (4t).
We also investigated germylation of aryl iodide 10 under the optimized conditions for aryl bromides (Scheme 1). The conditions for aryl bromides were effective to provide 4a in 95% yield at 80 °C, but the lower reaction temperature resulted in lower conversion. 
Scheme 1 Germylation of aryl iodide 10
When β-bromostyrene was used as a substrate, both Conditions A and Conditions B in Figure 2 afforded a dimerized product as a major product (see Supporting Information). Thus, the developed conditions were not suitable for germylation of alkenyl bromides.
The exact catalytic cycle was not elucidated, but a plausible cycle comprises oxidative addition of 1 or 2 to Pd(0), transmetalation with digermane 3, and reductive elimination to release arylgermane 4. The use of PPh3 as a ligand also afforded the product in moderate yield (Table 1 , entry 10), and therefore a hydroxy group of 5 would only have minor effects for the desired catalytic cycle, in contrast to the dramatic ligand effects observed in silylation. 9g The role of Et4NBr in germylation of aryl triflates was unclear. A tetraethylammonium ion might be important rather than a bromide ion (Table 1, entries 13-19) .
In summary, we developed general conditions for the germylation of aryl bromides 1 and aryl triflates 2 using hexamethyldigermane 3 under palladium catalysis. Various functionalized substrates, including drug-like molecules, afforded the germylated products in moderate to good yield, demonstrating the versatility of the presented protocols. These methods enable easy access to functionalized arylgermanes, and may encourage further investigation of the properties and reactivity of arylgermane derivatives.
The experimental section has no title; please leave this line here.
Procedures
General: Reported melting points were uncorrected. Infrared (IR) spectra were recorded on a JASCO FT/IR-5300 spectrophotometer and absorbance bands are reported in wave numbers (cm -1 ). NMR spectra were recorded on JEOL JNM-ECS400 spectrometers operating at 391. 1-(4-Bromophenethyl)piperidine 1f, [15] 5-bromo-1-tosyl-1H-indole 1g, [16] 2-bromobenzo[b]thiophene 1i, [17] and ethyl 8-bromo-5-methyl-6-oxo-5,6-dihydro-4H-benzo [f] imidazo[1,5-a][1,4]diazepine-3-carboxylate 1k [14] were synthesized according to the literature. Structures of bromides 1 and aryl triflates 2 are listed in Figure S1 in Supporting Information. Hexamethyldigermane 3 was purchased from Sigma-Aldrich and used as received. All other reagents were commercially available and used as received.
General Procedure for Germylation of Aryl Bromides and Triflates
Conditions A: To a screw vial with a septum cap were added aryl bromide 1 (0.50 mmol), Pd(OAc)2 (11.2 mg, 0.05 mmol, 10 mol %), ligand 5 (27.8 mg, 0.10 mmol, 20 mol %), Cs2CO3 (195.5 mg, 0.60 mmol, 1.2 equiv.), Et4NHCO3 (9.5 mg, 0.05 mmol, 10 mol %), hexamethyldigermane 3 (120 µL, 0.60 mmol, 1.2 equiv.) and toluene (1.25 mL) under Ar atmosphere in a glove box. The vial was capped and removed from the glove box, and then H2O (1.25 mL) was injected via syringe. The vial was heated at 100 °C for 24 h with stirring. After cooled to room temperature, the organic layer was separated, and the aqueous layer was extracted with EtOAc (3 mL × 3). The combined organic layers were washed with brine (3 mL), dried over Na2SO4. Filtration and evaporation gave a crude product, which was purified by silica gel column chromatography to give a corresponding product 4.
Conditions B:
To a dried screw capped vial were added aryl bromide 1 or aryl triflate 2 (0.50 mmol), Pd(OAc)2 (11.2 mg, 0.05 mmol, 10 mol %), Ligand 5 (27.8 mg, 0.10 mmol, 20 mol %), Cs2CO3 (195.5 mg, 0.60 mmol, 1.2 equiv.), Et4NBr (105.1 mg, 0.5 mmol, 1.0 equiv.), hexamethyldigermane 3 (120 µL, 0.60 mmol, 1.2 equiv.) and toluene (2.5 mL) under Ar atmosphere in a glove box. The vial was capped and heated at 120 °C for 24 h with stirring. After cooled to room temperature, H2O (2 mL) was added. After dilution with EtOAc, the organic layer was separated, and the aqueous layer was extracted with EtOAc (3 mL × 3). The combined organic layers were washed with brine (3 mL), and dried over Na2SO4. Filtration and evaporation gave a crude product, which was purified by silica gel column chromatography to give a corresponding product 4.
(4-Chlorophenyl)trimethylgermane (4a) Conditions A using 1-bromo-4-chlorobenzene 1a (0.50 mmol) and purification of the crude product by silica gel column chromatography (hexane) followed by gel permeation chromatography afforded 4a as a colorless oil (98.6 mg, 86% yield).
Conditions B using 4-chlorophenyl trifluoromethanesulfonate 2a (0.50 mmol) and purification of the crude product by silica gel column chromatography (hexane) afforded 4a as a colorless oil (95.1 mg, 83% yield). 13 C NMR (125 MHz, CDCl3): δ = 165. 8, 138.4, 138.0, 134.9, 133.7, 131.8, 128.7, 127.0, 119.7, -1.78 HRMS (ESI): m/z (M+Na + ) calcd for C16H19ON 70 GeNa: 334.0601; found: 334.0603
1-(4-(Trimethylgermyl)phenethyl)piperidine (4f)
Conditions B using 1-(4-bromophenethyl)piperidine 1f (268 mg, 1.0 mmol) and purification of the crude product by silica gel column chromatography (hexane/EtOAc = 6:1, 3% Et3N) afforded 4f as a yellow oil (255 mg, 83% yield).
TLC: Rf 0.38 (hexane/EtOAc = 6:1, 3% Et3N) IR (neat): 2969, 2934, 2853, 2798, 1758, 1235, 1155, 1120, 1090, 823, 757, 600, 572 6, 139.5, 132.9, 128.3, 61.3, 54.5, 33.5, 25.9, 24.4 
Tosyl-5-(trimethylgermyl)-1H-indole (4g)
Conditions A using 5-bromo-1-tosyl-1H-indole 1g and purification of the crude product by silica gel column chromatography (hexane/EtOAc = 10:1 to 8:1) and afforded 4g as a colorless solid (165 mg, 85% yield). 9, 136.6, 135.4, 135.0, 130.6, 129.9, 128.9, 126.8, 126.1, 126.0, 113.0, 108.7, 21.5, -1.62 HRMS (ESI): m/z (M+Na + ) calcd for C18H21O2N 70 GeNaS: 408.0428; found: 408.0442
6-(Trimethylgermyl)quinoline (4h)
Conditions A using 6-bromoquinoline 1h and purification of the crude product by silica gel column chromatography (hexane/EtOAc = 5:1) afforded 4h as a colorless oil (107 mg, 87% yield).
Conditions B using quinolin-6-yl trifluoromethanesulfonate 2h and purification of the crude product by silica gel column chromatography (hexane/EtOAc = 5:1) afforded 4h as a colorless oil (83.5 mg, 68% yield).
TLC: Rf 0.30 (hexane/EtOAc = 4:1) IR (neat): 2970, 2906, 1564, 1491, 1341, 1237, 1071, 856, 831, 799, 771, 623, 601, 587, 567 4, 148.3, 141.4, 135.8, 133.5, 132.8, 128.5, 127.9, 121.1, -1.77 HRMS (ESI): m/z (M+H + ) calcd for C12H16N 70 Ge: 244.0520; found: 244.0523
Benzo[b]thiophen-2-yltrimethylgermane (4i)
Conditions B using 2-Bromobenzo[b]thiophene 1i and purification of the crude product by silica gel column chromatography (hexane) followed by gel permeation chromatography afforded 4i as a colorless oil (87.1 mg, 69% yield).
TLC: Rf 0.67 (hexane/EtOAc = 20:1) IR (neat): 3056, 2973, 2907, 1453, 1240, 945, 826, 761, 744, 726, 605, 574 , 561 cm -1 1 H NMR (400 MHz, CDCl3): δ = 7.87 (d, J = 7.7 Hz, 1 H), 7.79 (d, J = 7.7 Hz, 1 H), 7.38 (s, 1 H), 7.35-7.26 (m, 2 H), 0.51 (s, 9 H) 13 C NMR (100 MHz, CDCl3): δ = 143. 7, 143.4, 141.1, 129.6, 124.1, 123.9, 123.2, 122.2, -0.53 HRMS (EI): m/z (M + ) calcd for C11H14 70 GeS: 248.0059; found: 248.0057
Ethyl 2-(4-bromophenoxy)-2-methylpropanoate (1k)
4-Bromophenol (519 mg, 3.0 mmol) and Cs2CO3 (2.44 g, 7.5 mmol, 2.5 equiv) were dissolved in anhydrous DMF (10 mL). The solution was stirred for 10 min, and then ethyl-2-bromoisobutyrate (1.17 g, 6.0 mmol, 2.0 equiv) was added. The resulting reaction mixture was stirred at 100 °C for 23 h. After cooled to room temperature, the residue was taken up in EtOAc (50 mL). The solution was successively washed with H2O (20 mL x 2) and brine (20 mL), and dried over Na2SO4. Filtration and evaporation gave a crude product, which was purified by silica gel column chromatography to give 1k as a colorless oil (818 mg, 95% yield).
TLC: Rf = 0.50 (hexane/EtOAc = 5:1) IR (neat): 2987, 2938, 1734, 1587, 1486, 1468, 1383, 1284, 1238, 1177, 1140, 1073, 1023, 1007, 825, 647 Conditions B using ethyl 2-(4-bromophenoxy)-2-methylpropanoate 1k (114.9 mg, 0.40 mmol), Pd(OAc)2 (20 mol %), and ligand 5 (40 mol %) and purification of the crude product by silica gel column chromatography (hexane/EtOAc = 10:1) followed by gel permeation chromatography afforded 4k as a colorless oil (84.4 mg, 65% yield).
TLC: Rf 0.63 (hexane/EtOAc = 5:1) IR (neat): 2977, 2906, 1733, 1590, 1498, 1382, 1272, 1237, 1178, 1142, 1093, 1024, 824, 761, 599 , 569 cm -1 1 H NMR (400 MHz, CDCl3): δ = 7.34-7.30 (m, 2 H), 6.84-6.80 (m, 2 H), 4.24 (q, J = 7.1 Hz, 2 H), 1.60 (s, 6 H), 1.25 (t, J = 7.1 Hz, 3 H), 0.34 (s, 9 H) 13 C NMR (125 MHz, CDCl3): δ = 174. 3, 155.7, 134.8, 133.8, 118.4, 78.8, 61.4, 25.4, 14. 3112, 2975, 2905, 1728, 1704, 1647, 1503, 1296, 1260, 1189, 1109, 1065, 833, 605 cm -1 1 H NMR (400 MHz, CDCl3): δ = 8. 15 (d, J = 1.4 Hz, 1 H), 7.90 (s, 1 H), 7.72 (dd, J = 7.7, 1.4 Hz, 1 H), 7.38 (d, J = 7.7 Hz, 1 H), 1 H), 3 H), 3.26 (s, 3 H), 1.46 (t, J = 7.2 Hz, 3 H), 0.45 (s, 9 H) 13 C NMR (125 MHz, CDCl3): δ = 166. 8, 162.9, 144.1, 137.1, 136.8, 135.5, 134.8, 131.8, 128.5, 128.0, 120.9, 60.8, 42.2, 35.7, 14.3, -1.9 HRMS ( 3421, 2961, 2905, 2865, 1383, 1267, 1235, 1078, 818, 760, 602, 576, 552 cm -1 1 H NMR (400 MHz, CDCl3): δ = 7.44-7.41 (m, 2 H), 7.40-7.37 (m, 2 H), 1.32 (s, 9 H), 0.37 (s, 9 H) 13 C NMR (100 MHz, CDCl3): δ = 151. 1, 138.9, 132.8, 124.9, 34.6, 31.3, -1.79 HRMS ( 2976, 2906, 1719, 1410, 1365, 1261, 1172, 1116, 1071, 826, 742, 602, 570 13 C NMR (125 MHz, CDCl3): δ = 167. 0, 143.0, 137.4, 133.9, 129.8, 129.4, 127.8, 60.9, 14.4, -1.83 HRMS ( 7, 127.8, 127.5, 127.1, 123.8, 121.8, 121.8, 121.3, 119.9, 119.8, -8.13 HRMS ( 
Conditions
B using (8R,9S,13S)- 13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a] 3454, 2969, 2928, 2866, 2837, 1739, 1452, 1235, 1081, 828 , 603 cm -1 1 H NMR (CDCl3, 500 MHz): δ = 7.32-7.27 (m, 2 H), 7.22 (s, 1 H), 2.94 (dd, J = 8.9, 4.3 Hz, 2 H), 2.51 (dd, J = 18.9, 8.6 Hz, 1 H), 2.47-2.41 (m, 1 H), 2.36-2.29 (m, 1 H), 2.19-1.94 (m, 4 H), 1.68-1.59 (m, 2 H), 0.90 (s, 3 H), 0.37 (s, 9 H) 13 C NMR (125 MHz, CDCl3): δ = 220. 7, 139.8, 139.4, 135.9, 133.7, 130.4, 124.9, 50.4, 47.9, 44.4, 38.0, 35.8, 31.5, 29.3, 26.5, 25.5, 21.5, 13.7, -1.84 HRMS (ESI): m/z (M+Na + ) calcd for C21H30O 70 GeNa: 391.1431; found: 391.1431
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(trimethylgermyl)phenyl)propanoate (4u)
Conditions B using methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(((trifluoromethyl)sulfonyl)oxy)phenyl)propanoate 2u and KOAc instead of Cs2CO3 for 62 h, and purification of the crude product by silica gel column chromatography (hexane/EtOAc = 10:1) afforded 4u as a colorless solid (132.6 mg, 67 % yield).
TLC: Rf = 0.50 (EtOAc/MeOH = 9:1) M.p.: 55.5-56.2 °C IR (KBr): 3370, 2975, 1747, 1717, 1500, 1437, 1366, 1248, 1214, 1168, 825, 757, 600, 568 3, 155.0, 140.9, 135.9, 133.1, 128.9, 79.8, 54.3, 52.2, 38.2, 28.3, -1 
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